GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 13 or. 2 percent, to $75.53. Bristol-Myers Squibb Co. rose$. 04 or. 1 percent, to $50.77. Hospira fell$. 56 or 1.0 percent, to $54.04.

  • Midday Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 1:31 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $75.52. Bristol-Myers Squibb Co. fell$. 02 or percent, to $50.71. Hospira fell$. 22 or. 4 percent, to $54.38.

  • Most active New York Stock Exchange-traded stocks Tuesday, 26 Aug 2014 | 1:31 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. rose. 2 percent to $16.33 with 61,753,500 shares traded. Best Buy Co. fell 6.8 percent to $29.80 with 24,954,800 shares traded.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Early Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 11:12 AM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $75.46. Bristol-Myers Squibb Co. rose$. 12 or. 2 percent, to $50.85. Johnson& Johnson rose$. 06 or. 1 percent, to $103.29.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Pfizer/AstraZeneca: Ready for round 2? Tuesday, 26 Aug 2014 | 3:16 AM ET

    The potential for Pfizer to take over AstraZeneca has sent its prey’s share price soaring and caused political ructions on both sides of the Atlantic.

  • Pfizer and Astrazeneca: Round 2?     Tuesday, 26 Aug 2014 | 1:45 AM ET

    CNBC's Catherine Boyle reports on whether Pfizer might make another bid for Astrazeneca three months after the collapse of its £69.4 billion ($115.14 billion) approach.

  • Most active New York Stock Exchange-traded stocks Monday, 25 Aug 2014 | 6:24 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. was unchanged at $34.51 with 14,563,200 shares traded. Bank of America Corp. rose 1.0 percent to $16.29 with 87,011,700 shares traded.

  • Final Glance: Pharmaceuticals companies Monday, 25 Aug 2014 | 6:24 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $75.40. Bristol-Myers Squibb Co. rose$. 55 or 1.1 percent, to $50.73. Johnson& Johnson rose$. 13 or. 1 percent, to $103.23.

  • Bankers and lawyers providing takeover advice said on Monday that Burger King Worldwide Inc's intention to move its tax domicile overseas through a so-called inversion deal- in this case the purchase of Canada's Tim Hortons- shouldn't be seen as a sign of a lot more deals to come.

  • There's still hunger for 'blockbuster' biotech deals Monday, 25 Aug 2014 | 10:58 AM ET
    Severin Schwan, chief executive officer Roche Holding.

    Roche's deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech.

  • Early Glance: Pharmaceuticals companies Monday, 25 Aug 2014 | 10:37 AM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $75.49. Bristol-Myers Squibb Co. rose$. 34 or. 7 percent, to $50.52. Hospira rose$. 28 or. 5 percent, to $54.88.

  • *Deal boosts Roche presence in respiratory medicine. LONDON/ ZURICH, Aug 24- Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

  • Final Glance: Pharmaceuticals companies Friday, 22 Aug 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 76 or 1.0 percent, to $75.04. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $50.18. Hospira fell$. 14 or. 3 percent, to $54.60.

  • Midday Glance: Pharmaceuticals companies Friday, 22 Aug 2014 | 1:22 PM ET

    Baxter International Inc. fell$. 57 or. 8 percent, to $75.23. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $50.15. Hospira fell$. 13 or. 2 percent, to $54.61.

  • Most active New York Stock Exchange-traded stocks Friday, 22 Aug 2014 | 1:22 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. fell. 2 percent to $16.13 with 105,702,200 shares traded. Citigroup Inc. fell. 3 percent to $50.93 with 19,819,600 shares traded.

  • Final Glance: Pharmaceuticals companies Thursday, 21 Aug 2014 | 6:08 PM ET

    Baxter International Inc. rose$. 55 or. 7 percent, to $75.80. Bristol-Myers Squibb Co. fell$. 05 or. 1 percent, to $49.99. Hospira fell$. 17 or. 3 percent, to $54.74.

  • FDA clears Eliquis for new use against blood clots Thursday, 21 Aug 2014 | 3:10 PM ET

    WASHINGTON— Bristol-Myers Squibb and Pfizer said Thursday that federal regulators have expanded approval of their blood thinner Eliquis to treat two types of dangerous blood clots. The Food and Drug Administration cleared the drug for patients suffering from or at risk of deep vein thrombosis and pulmonary embolism.

  • Most active New York Stock Exchange-traded stocks Thursday, 21 Aug 2014 | 1:22 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Bank of America Corp. rose 2.6 percent to $15.92 with 71,947,500 shares traded. Citigroup Inc. rose 1.5 percent to $50.56 with 8,811,400 shares traded.